Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PARATHAR

TERIPARATIDE ACETATE

Standard Dose
200 UNITS/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PARATHAR is listed in Drugs@FDA under application 019498 (NDA).

Marketing status: Discontinued Active ingredient TERIPARATIDE ACETATE Form and strength INJECTABLE;INJECTION - 200 UNITS/VIAL Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview PARATHAR is listed in Drugs@FDA under application 019498 (NDA). Marketing status: Discontinued Active ingredient TERIPARATIDE ACETATE Form and strength INJECTABLE;INJECTION - 200 UNITS/VIAL Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Monitoring

  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PARATHAR (TERIPARATIDE ACETATE) | Drug Monograph | MedicHelpline